CRIS Current Research Information System

COLANGELI, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.342
EU - Europa 915
AS - Asia 341
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 2.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.340
GB - Regno Unito 232
SE - Svezia 211
IT - Italia 139
CN - Cina 138
VN - Vietnam 113
DE - Germania 111
IE - Irlanda 63
IN - India 62
TG - Togo 49
UA - Ucraina 42
RU - Federazione Russa 36
FR - Francia 33
JO - Giordania 24
EE - Estonia 21
ZA - Sudafrica 20
BE - Belgio 15
CI - Costa d'Avorio 10
NG - Nigeria 7
CH - Svizzera 6
EU - Europa 3
CL - Cile 2
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
FI - Finlandia 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
JP - Giappone 1
LB - Libano 1
MS - Montserrat 1
MX - Messico 1
RO - Romania 1
SC - Seychelles 1
Totale 2.690
Salva come PNG Salva come JPEG
Città #
Southend 209
Fairfield 182
Chandler 158
Woodbridge 104
Ashburn 99
Houston 88
Seattle 82
Wilmington 69
Dublin 63
Princeton 61
Cambridge 58
Dong Ket 52
Bologna 49
Lomé 49
Ann Arbor 47
Nanjing 27
Westminster 26
Florence 25
Amman 24
Berlin 23
Padova 20
Jacksonville 18
Brussels 15
Jinan 14
Saint Petersburg 14
Hebei 13
San Diego 13
Turin 13
Dearborn 12
Redmond 12
Abidjan 10
Beijing 9
Des Moines 9
Shenyang 9
Changsha 8
Olalla 8
Abeokuta 7
Nanchang 7
Boardman 6
Bremen 6
Ningbo 6
Rome 6
Tianjin 6
Bern 5
Falls Church 5
Jiaxing 5
Lanzhou 5
Taizhou 5
Zhengzhou 5
Milan 4
Boydton 3
Hangzhou 3
Hefei 3
Los Angeles 3
Mountain View 3
Mülheim 3
Norwalk 3
Guangzhou 2
Hanover 2
Islington 2
London 2
New York 2
Orange 2
Redwood City 2
Taiyuan 2
Andover 1
Avola 1
Benevento 1
Brno 1
Buffalo 1
Carol Stream 1
Chiswick 1
Copenhagen 1
Dallas 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Gunzenhausen 1
Haikou 1
Kunming 1
Kyiv 1
Leawood 1
Mahé 1
Medford 1
Napoli 1
Paris 1
Pavullo Nel Frignano 1
Pune 1
Qingdao 1
Saint Louis 1
San Mateo 1
Shanghai 1
Tappahannock 1
Tokyo 1
Torino 1
Veracruz 1
Verona 1
Wayne 1
Wenzhou 1
Totale 1.841
Salva come PNG Salva come JPEG
Nome #
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 123
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 118
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 114
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 113
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 113
null 113
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 110
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 109
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection. 107
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 104
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. 100
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 99
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 98
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 97
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 97
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 97
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 95
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 93
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. 93
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 90
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 85
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia 83
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. 82
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy 81
Raltegravir use prospectically assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile 73
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infection 63
Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy 62
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir 54
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up 54
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients 30
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir 12
Totale 2.762
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.839
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019100 0 0 0 0 0 19 4 10 7 27 3 30
2019/2020716 96 19 4 41 74 71 91 96 110 57 25 32
2020/2021365 89 22 10 13 10 15 5 10 36 20 15 120
2021/2022633 54 27 35 79 66 26 12 24 19 110 104 77
2022/2023699 50 100 23 94 42 43 13 61 156 19 68 30
2023/2024111 13 30 10 34 13 11 0 0 0 0 0 0
Totale 2.762